The ARO @-@ trial primarily compared wait-and-see ( WS , arm A ) with adjuvant radiation therapy ( ART , arm B ) in prostate cancer patients who achieved an undetectable prostate-specific antigen ( PSA ) after radical prostatectomy ( RP ) .